PUBMED FOR HANDHELDS

Journal Abstract Search


670 related items for PubMed ID: 16540560

  • 1. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 2. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Nov; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
    Turk J Pediatr; 1999 Nov; 41(2):225-30. PubMed ID: 10770662
    [Abstract] [Full Text] [Related]

  • 7. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM.
    J Nephrol; 1997 Nov; 10(5):266-70. PubMed ID: 9364319
    [Abstract] [Full Text] [Related]

  • 8. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 9. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F.
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [Abstract] [Full Text] [Related]

  • 11. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
    Norero C, Delucchi A, Lagos E, Rosati P.
    Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
    [Abstract] [Full Text] [Related]

  • 12. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 13. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 14. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
    J Nephrol; 2005 Oct; 18(6):711-20. PubMed ID: 16358229
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
    Wasilewska A, Zoch-Zwierz W, Tenderenda E.
    Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
    Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ.
    Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
    [Abstract] [Full Text] [Related]

  • 17. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Feb 20; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 19. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
    Am J Kidney Dis; 1998 Jun 20; 31(6):932-9. PubMed ID: 9631836
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T, Ksiazek J, Wieteska-Klimczak A, Gorzkowska-Paczwa M, Dorywalski T, Tysarowska A.
    Pol Merkur Lekarski; 2001 Aug 20; 11(62):140-3. PubMed ID: 11757213
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.